Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the superiority of YM150 to the placebo and to
evaluate the dose-dependent response of YM150 in patients undergoing elective total hip
replacement surgery.